For full functionality of this site it is necessary to enable JavaScript. Here are the instructions how to enable JavaScript in your web browser.

We are availabe to talk to you Monday - Friday 9am - 5pm

GDPR text - this is just a placeholder until correct text is inserted.

Have a member of our team call you back.

GDPR text - this is just a placeholder until correct text is inserted.

You can email us your enquiry by completing the form below.

Donec nisl risus, mattis ut, porttitor vitae, lobortis sagittis, lacus. Nullam neque ligula, congue at, fringilla at, consequat vitae, nulla. Nam ut felis. Curabitur imperdiet ligula a leo molestie malesuada. Praesent neque tortor, placerat accumsan, imperdiet non, iaculis at, mauris. In lacus quam, semper in, ullamcorper et, hendrerit id, pede. Nulla pretium sodales nunc.

Quisque augue quam, pulvinar in, accumsan et, pellentesque sed, ligula. Proin viverra, quam et aliquam molestie, turpis enim pellentesque eros, nec varius sem est id sapien. Aliquam at orci. Cras enim. Nam magna quam, elementum a, aliquet at, eleifend id, lacus. Donec et odio id quam laoreet suscipit.

Quisque ac ante. Aenean in neque. Suspendisse aliquet tincidunt pede. Duis mi. Morbi sapien. Cras posuere interdum nisl. Proin ac eros. Integer sit amet odio. Nullam nec velit dapibus augue condimentum egestas. Phasellus quis odio. Sed semper aliquet risus. Integer gravida vulputate sem. Praesent eu mauris. Fusce consequat congue dui. Vivamus quis metus non dui pellentesque tempor.

Morning Briefing

Davy Morning Equity Briefing

Apr 24, 2025

CVS Group

Disposal of crematoria division

After receiving an attractive offer of 10x EV/EBITDA for its crematoria division, CVS has announced its disposal for £42.4m. The capital will be recycled into further acquisitions in Australia. The disposal highlights the material undervaluation of the rest of the group.

Colin Grant
Morning briefing
Read Important Disclosures

Morning Briefing

Jump to

Davy Morning Equity Briefing

Apr 24, 2025

CVS Group